Item no. |
GLE-H52H3-1mg |
Manufacturer |
ACROBiosystems
|
Amount |
1 mg |
Quantity options |
100 ug
1 mg
20 ug
|
Category |
|
Type |
Proteins Recombinant |
Format |
Liquid |
Specific against |
Human (Homo sapiens) |
Host |
HEK293 |
Conjugate/Tag |
Unconjugated, HIS |
Purity |
90% |
Dry ice |
Yes
|
NCBI |
NP_001005741.1 |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Alias |
Glucosylceramidase,GBA,Acid beta-glucosidase,Alglucerase,beta-glucocerebrosidase,D-glucosyl-N-acylsphingosine glucohydrolase,EC 3.2.1.45,GBA,GBA1,GC,GCB,GLUC,glucosidase, beta, acid,glucosidase, beta,acid (includes glucosylceramidase),Glucosylceramidase,I |
Shipping condition |
Dry ice |
Available |
|
Manufacturer - Category |
Protein / Enzymes |
Manufacturer - Conjugate / Tag |
Unconjugated, C-10xHis |
Shipping Temperature |
Dry ice |
Storage Conditions |
-70°C |
Molecular Weight |
57.5 kDa |
Description |
Human Glucosylceramidase, His Tag (GLE-H52H3) is expressed from human 293 cells (HEK293). It contains AA Ala 40 - Gln 536 (Accession # P04062-1). |
Background |
Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramide/GlcCer into free ceramide and glucose. Thereby, it plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, it participates in the PKC-activated salvage pathway of ceramide formation and plays a role in cholesterol metabolism. It may either catalyze the glucosylation of cholesterol, through a transglucosylation reaction that transfers glucose from glucosylceramide to cholesterol. Defects in Glucosylceramidase are the cause of Gaucher disease, also known as glucocerebrosidase deficiency. Gaucher disease is the most prevalent lysosomal storage disease, characterized by accumulation of glucosylceramide in the reticulo-endothelial system. Currently, enzyme replacement therapy is used to treat patients with the disease. |
Molecule |
Glucosylceramidase |
Exp Region |
Ala 40 - Gln 536 |
Characteristics |
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 57.5 kDa. The protein migrates as 60-66 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
Endotoxin |
1.0 EU per μg |
Buffer |
PBS |
Stability |
● The product MUST be stored at -70°C or lower upon receipt; ● -70°C for 3 months under sterile conditions. |
Protectant |
Glycerol |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.